EFX Form 144 Filed — 4,553 Common Shares Proposed Sale via Fidelity

Rhea-AI Filing Summary

Form 144 notice by an Equifax insider to sell common stock. The filer intends to sell 4,553 shares of Equifax common stock through Fidelity Brokerage Services on the NYSE, with an aggregate market value reported as $1,111,895.40 and total shares outstanding listed as 123,797,380. The securities to be sold derive from stock options granted on 11/01/2019 (722 shares) and 09/28/2018 (3,831 shares); payment is shown as cash and the approximate date of sale is 08/29/2025. The filing indicates no securities were sold by the reporting person in the past three months and includes the standard representation that the seller knows of no undisclosed material adverse information about the issuer.

Positive

• Required disclosure provided showing broker, share count, aggregate value, and acquisition details
• No reported sales in prior three months, simplifying aggregation considerations under Rule 144

Negative

• Insider proposes to sell 4,553 shares with an aggregate market value of $1,111,895.40
• The filing does not state whether the sale is part of a Rule 10b5-1 trading plan

Insights

Securities Analyst

TL;DR: Insider plans to sell 4,553 shares (~$1.11M) via Fidelity on the NYSE; sale stems from prior option grants.

The filing is a routine Rule 144 notice disclosing a proposed sale of Equifax common stock totaling 4,553 shares with an aggregate market value of $1,111,895.40. The securities originate from options granted in 2018 and 2019 and are to be sold for cash. The document reports no sales in the prior three months, which may be relevant when aggregating permitted sales under Rule 144, but the filing itself provides no explanation of intent or timing beyond the approximate sale date of 08/29/2025. For investors, this is a disclosure of an insider liquidity event; the filing contains no financial performance data or new issuer-specific developments.

Corporate Governance Expert

TL;DR: Proper Rule 144 procedure appears followed; disclosure lists option origins and brokerage channel.

The notice supplies required information: class of shares, broker name and address, number of shares, aggregate market value, acquisition dates and nature (options granted), and representation regarding material non-public information. The filing does not state whether the sale is part of a trading plan or related to Rule 10b5-1, though it references the trading-plan representation text. From a governance standpoint, the form meets disclosure obligations but contains no additional governance or related-party detail.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	4553	1111895.40	123797380	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/29/2025	Option Granted - 11/01/2019	Issuer			722	08/29/2025	Cash
Common	08/29/2025	Option Granted - 09/28/2018	Issuer			3831	08/29/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for EFX disclose?

It discloses a proposed sale of 4,553 shares of Equifax common stock through Fidelity, with an aggregate market value of $1,111,895.40 and an approximate sale date of 08/29/2025.

Where did the securities being sold originate?

The securities derive from stock options: 722 shares from an option granted 11/01/2019 and 3,831 shares from an option granted 09/28/2018; payment is listed as cash.

Was any sale by the reporting person made in the past three months?

The filing states Nothing to Report under securities sold during the past three months.

Through which broker will the sale occur and on which exchange?

The broker listed is Fidelity Brokerage Services LLC (900 Salem Street, Smithfield RI) and the exchange is the NYSE.

Does the Form 144 state the seller is aware of any undisclosed material information?

By signing the notice the person represents they do not know any material adverse information about the issuer that has not been publicly disclosed.